| scholarly article | Q13442814 |
| P50 | author | Jonas Mattsson | Q44779136 |
| Emelie Rådestad | Q92308095 | ||
| P2093 | author name string | M Engström | |
| M Uhlin | |||
| M Uzunel | |||
| B Sundberg | |||
| E Watz | |||
| H Wikell | |||
| S Thunberg | |||
| E Rådestad | |||
| P2860 | cites work | Graft failure after allogeneic hematopoietic cell transplantation | Q37045988 |
| Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation | Q37552052 | ||
| Targeting γδ T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application | Q37821134 | ||
| Negative depletion of α/β+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation | Q38148915 | ||
| Targeting gamma delta T cells for cancer immunotherapy: bench to bedside | Q38179172 | ||
| Bone marrow transplantation using unrelated donors for haematological malignancies | Q40901324 | ||
| Graft-versus-leukemia reactions after bone marrow transplantation | Q41198977 | ||
| Help signals provided by lymphokines modulate the activation and apoptotic programs induced by partially agonistic peptides in specific cytotoxic T lymphocytes | Q44212173 | ||
| Potential regulatory role of in vitro-expanded Vδ1 T cells from human peripheral blood | Q44728053 | ||
| Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission | Q44978580 | ||
| A large-scale method for the selective depletion of alphabeta T lymphocytes from PBSC for allogeneic transplantation | Q46965159 | ||
| Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation. EBMT Immunology and Chronic Leukemia Working Parties | Q47686713 | ||
| Six-of-the-best: unique contributions of γδ T cells to immunology | Q27010451 | ||
| Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma | Q33608520 | ||
| Implication of gammadelta T cells in the human immune response to cytomegalovirus | Q33854964 | ||
| Advances in graft-versus-host disease biology and therapy | Q34031916 | ||
| Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role | Q34086212 | ||
| Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. | Q35606345 | ||
| Pathophysiology of graft-versus-host disease | Q36368101 | ||
| Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells | Q36403003 | ||
| Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self | Q36652207 | ||
| Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection | Q36835155 | ||
| Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update. | Q50911359 | ||
| Outcome of boost haemopoietic stem cell transplant for decreased donor chimerism or graft dysfunction in primary immunodeficiency | Q57122103 | ||
| Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study | Q58789014 | ||
| Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantation | Q61053497 | ||
| CD34+stem cell top-ups without conditioning after initial haematopoietic stem cell transplantation for correction of incomplete haematopoietic and immunological recovery in severe congenital immunodeficiencies | Q61053885 | ||
| Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma | Q62735497 | ||
| Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation | Q63257360 | ||
| Gamma delta T lymphocyte regeneration after T lymphocyte-depleted bone marrow transplantation from mismatched family members or matched unrelated donors | Q71100864 | ||
| Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients | Q72009940 | ||
| Reconstitution of gammadelta T cell repertoire diversity after human allogeneic hematopoietic cell transplantation and the role of peripheral expansion of mature T cell population in the graft | Q74082715 | ||
| Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation | Q74810092 | ||
| Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-back | Q77231062 | ||
| Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation | Q77378864 | ||
| CD34 selection using three immunoselection devices: comparison of T-cell depleted allografts | Q77937953 | ||
| Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation | Q80196080 | ||
| Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor | Q81909391 | ||
| Unmanipulated donor lymphocytes for EBV-related PTLD after T-cell depleted HLA-haploidentical transplantation | Q82822286 | ||
| Human cytomegalovirus-specific T cell reconstitution in young patients receiving T cell-depleted, allogeneic hematopoietic stem cell transplantation | Q83393081 | ||
| Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation | Q84074293 | ||
| T-cell depletion of allogeneic bone marrow grafts: enrichment of mononuclear cells using the COBE Spectra cell processor, followed by immunoselection of CD34(+) cells | Q84157869 | ||
| Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusions | Q84392996 | ||
| The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation | Q84473603 | ||
| γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia | Q85818563 | ||
| Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device | Q87339052 | ||
| CD34 selected cells for the treatment of poor graft function after allogeneic stem cell transplantation | Q87955921 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | immunology | Q101929 |
| stem cell transplantation | Q65592366 | ||
| P304 | page(s) | 578741 | |
| P577 | publication date | 2014-10-13 | |
| P1433 | published in | Journal of Immunology Research | Q26841936 |
| P1476 | title | Alpha/beta T-cell depleted grafts as an immunological booster to treat graft failure after hematopoietic stem cell transplantation with HLA-matched related and unrelated donors | |
| P478 | volume | 2014 |
| Q92407428 | 'Off-the-shelf' allogeneic CAR T cells: development and challenges |
| Q38526017 | Biomarkers in Hematological Malignancies: A Review of Molecular Testing in Hematopathology |
| Q48181290 | CD34+ selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantation. |
| Q47289766 | Cell therapies for hematological malignancies: don't forget non-gene-modified t cells! |
| Q90182584 | Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT |
| Q89777680 | Developing T-cell therapies for lymphoma without receptor engineering |
| Q47267330 | Developing T-cell therapies for lymphoma without receptor engineering. |
| Q92095447 | Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD |
| Q55008660 | Expansion of Gammadelta T Cells from Cord Blood: A Therapeutical Possibility. |
| Q40217705 | Functionality testing of stem cell grafts to predict infectious complications after allogeneic hematopoietic stem cell transplantation. |
| Q26767501 | Haploidentical Hematopoietic Stem Cell Transplantation: Expanding the Horizon for Hematologic Disorders |
| Q64249488 | Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion |
| Q36285222 | Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease |
| Q26750995 | Recent advances in haploidentical hematopoietic stem cell transplantation using ex vivo T cell-depleted graft in children and adolescents |
| Q48589811 | Tracking T-cell immune reconstitution after TCRαβ/CD19-depleted hematopoietic cells transplantation in children. |
| Q50225357 | αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation. |
Search more.